Jul 2021 – Sep 2022 · 1 yr 2 mos · United Arab Emirates

Feb 2020 – Jun 2021 · 1 yr 4 mos · Saudi Arabia

Jan 2019 – Jan 2020 · 1 yr

• Medical Manager Immunology, Oncology, Immuno-Oncology (IO) & Hematology.
• Biosimilar Concept awareness.
• Strategic planning of country medical plan and manage KOLs engagement plans.

Jan 2017 – Dec 2018 · 1 yr 11 mos

• Responsible for Pain and Anti-Infective franchises in Saudi Arabia.
• Responsible for GIT Franchise.
• Responsible for OTC portofolio.
• Achivement:
• Award for contribution in SANDOZ achievement 2017, as a member of marketing department,
• January 2018.
• Diclac (Diclofenac sodium) achieved 32.7% Gr. in term of value & units while its defined marked
• declined by -12.8% and -14.6% in term of units and value respectively.
• Diclac achieved +4.4% ppt MS gain in term of units & +4.1% ppt MS gain in term of value in year
• 2017.
• Diclac jumped from rank No. 5 to rank No. 2 in its defined market in term of units and value in
• year 2017.

Jun 2015 – Dec 2016 · 1 yr 6 mos · Saudi Arabia

• Responsible for CVS, Diabetes, Gastroenterology and CNS products.
• Developing Marketing Plans for new & existing products in KSA.
• Training for field force & field visits to evaluate implementation of Marketing Plan, create direct
• link with KOLs & handle objections on medical and promotional part.
• Prepare and make presentations for events like cycle Meetings, annual conference, new
• Product Launches and departmental meetings.
• Achievement
• Year 2016, Gasec achieved 12.5% Gr. in term of units, while the defined MKT Gr. is 2.5%, with
• MS% gain 1.3% ppt Vs. year 2015.
• Year 2016, Gasec achieved 15.7% Gr. in term of value, while the defined MKT Gr. is 2.1%, with
• MS% gain 1.2% ppt Vs. year 2015.
• Year 2016, Gasec 40mg achieved 19.3% & 23.3% Gr. in term of units & value respectively while
• the defined MKT showed almost flat growth, -0.1% & 1.1% in term of units & value respectively.
• Year 2016, Gasec 40mg achieved +1.5% ppt MS% gain in term of units & +1.6% ppt MS% gain in
• term of value.
• Year 2016, Gasec achieved 13.4% Gr. (its defined MKT Gr. was 0.9%) and gain 1.4% ppt MS%.

Jan 2014 – Mar 2015 · 1 yr 2 mos

• Achievement:
• Q1 2015 KSA MKT:
• Sortiva came in 3rd Rank with RX-MS 13.4 % , PPG : 119 % and total generated 21,949
• Rxs(+11,930 Rxs).
• Cardiology segment shows a dramatic growth for generated Sortiva RX by 1014 % with generated
• 6601 Rxs (+ 6000 Rxs).
• General practitioner segment shows a high growth for generated Sortiva RX by 89.8 % with
• generated 10,111 Rxs (+ 4785 Rxs).
• Sortiva-H came in 4th Rank with RX-MS 8.5 % ,PPG : 76.5 % and total generated 11,022 Rxs
• (+4777 Rxs).
• Cardiology segment shows a dramatic growth for generated Sortiva Rxs by 313.7 % with
• generated Rxs 5530 Rxs (+ 4193 Rxs).
• Tovast came in 3rd Rank after Lipitor & Crestor with RX-MS 7.5 % (MAT 3/2015).

Jan 2012 – Dec 2013 · 1 yr 11 mos

• Key Responsibilities:
• Developing Marketing Plans for new & existing products in KSA, Lebanon & rest of GCC countries.
• Training of Field force.
• Field visits to evaluate implementation of Marketing Plan, create direct link with KOLs & handle objection on medical and promotional part.
• Search & Retrieval of scientific data for Internet, Books , Magazine etc.
• Prepare and make presentations for events like cycle Meetings, annual Conference, new Product Launches, intra- and Inter departmental meetings.
• Learn retrieval of Data from ims, SAP and other electronic resources and make reports.
• Key Achievements:
• Close 2013 with 4% added MOS (from 4.7% to 8.7%) in Tovast Rx in KSA MKT within 2 years.
• Tovast added 81,000 Rxs to SPIMACO company total Rxs within 2 years.
• Conduct Tovast (Atorvastatin) launch in Lebanon, March 2012.
• Conduct Tovast (Atorvastatin) relaunch in Kuwait, April 2012.
• Conduct Sortiva (Losartan) launch in UAE, September 2012.

Jan 2010 – Dec 2011 · 1 yr 11 mos

• Conduct medical training for the company products as per assignment in the following theraputic areas: Cardovascular area, DM, Gastroentrology, Allergology & NSAIDs.
• Review promotional materials.
• Share in Medico-Marketing communications, supporting the marketing and promotion & sales teams, ensure compliance with medical ethics and meet the requirements of the healthcare authorities.
• Review regulatory guidelines regarding PSUR and Pharmacovigilance system and respond to regulatory authority comments.
• Create assigned parts of CTD, stay current regarding CTD regulatory guidelines and respond to regulatory authority comments.

Jul 2008 – Dec 2009 · 1 yr 5 mos

• Conduct medical information search as requested from sales and marketing team.
• Create Regulatory materials “Package inserts, outer packs, registration files” (English and Arabic) for new products.
• Reviews and updates existing regulatory materials.
• Help in preparing training manuals.
• Conduct medical training of products.
• Contact the drug regulator y authorities in a lot of countries where SPIMACO seeking to register new pharmaceutical products or follow up already registered products (e.g. Jordan, Kuwait, UAE, Oman & Sudan).
• Attend scientific symposia as well as administrative workshops in order to keep and develop an appropriate educational level for professional services
• Establish excellent relations with other functions in the organization.

Jul 2006 – Jun 2008 · 1 yr 11 mos

• Cover & manage a large area including Jeddah, Makkah, Madina, Hada, Taef, Khamees Masheet & Tabouk.
• Introduce new CV products in Key Accounts.
• Establish a relationship with new customers (Cardiologists).
• Work strategically to increase the awareness and use of a SPIMACO ADDWAEIH’s pharmaceutical and medical products in settings such as general practices, primary care centers and hospitals.
• Make presentations and organize group events for healthcare professionals, as well as working with contacts on a one-to-one basis to ensure clients are aware of, buy and subsequently use my company's products.

Aug 2005 – Jun 2006 · 10 mos · Egypt

• • I participated in launch of Aprovel® (Irbesartan) which is a worldwide antihypertensive brand – My job is promoting my product to the specialized doctors to prescribe it to their patients in the compiling indications based on the up to date medical guidelines and highlighting my product competitive advantages to achieve my money wise target.